Jiangsu BioXinkang Pharmaceutical Technology

Jiangsu BioXinkang Pharmaceutical Technology is a specialized pharmaceutical company headquartered in the China Medical City (Taizhou), Jiangsu Province. The company focuses on the research, development, and commercialization of high-end generic drugs and improved new drugs (Class 2), particularly in the fields of cardiovascular, cerebrovascular, and metabolic diseases. BioXinkang utilizes advanced formulation platforms, including sustained-release, controlled-release, and complex solid dispersion technologies, to enhance drug delivery and patient compliance. Its portfolio features several fixed-dose combination therapies designed to treat chronic conditions like hypertension and hyperlipidemia simultaneously. The company maintains integrated R&D and GMP-compliant manufacturing facilities to support its pipeline from discovery through to market supply. BioXinkang aims to address significant unmet clinical needs in China's aging population through high-quality, affordable therapeutic solutions.